BLUF
Experimental weight-loss peptides such as Retatrutide are increasingly being bought online and injected by Australians despite being illegal and unapproved. The trend is driving demand for injection equipment and raising concerns about health risks.Learning Outcomes
- Explain the risks associated with purchasing and using unapproved peptides, and quality concerns linked to experimental substances such as Retatrutide.
- Analyse how social media, online marketplaces, and international supply chains facilitate access to illicit or unregulated health products.
- Evaluate the role of harm reduction, surveillance, and consumer education strategies in addressing emerging public health risks associated with the growing use of peptides.
